← Back to patent-cliff list
CAS 951-82-6
2-(3,4,5-trimethoxyphenyl)acetic acid
Codes: DX1002-001, RIMI-001
Application context (from source-drug indications)
Hepatocellular carcinomaDX1002食管胃结合部肿瘤DX1002Gastric cancerDX1002Liver cancerDX1002Solid tumourDX1002大B细胞淋巴瘤RimiducidHodgkin's diseaseRimiducidNon-Hodgkin lymphomaRimiducid骨硬化症Rimiducid血红蛋白病Rimiducid血细胞减少症Rimiducid
Source drugs (routes using this intermediate)
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(3,4,5-trimethoxyphenyl)acetic acid→2-(3,4,5-trimethoxyphenyl)butanoic acid→(R)-4-benzyloxazolidin-2-one→(4R)-4-benzyl-3-(2-(3,4,5-trimethoxyphenyl)butanoyl)oxazolidin-2-one→(S)-2-(3,4,5-trimethoxyphenyl)butanoic acid→methyl (S)-piperidine-2-carboxylate→(S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylic acid→tert-butyl (R)-2-(3-(3-(3,4-dimethoxyphenyl)-1-hydroxypropyl)phenoxy)acetate→(R)-1-(3-(2-(tert-butoxy)-2-oxoethoxy)phenyl)-3-(3,4-dimethoxyphenyl)propyl (S)-1-((S)-2-(3,4,5-trimethoxyphenyl)butanoyl)piperidine-2-carboxylate→3,4-dimethoxybenzaldehyde→1-(3-hydroxyphenyl)ethan-1-one→(E)-3-(3,4-dimethoxyphenyl)-1-(3-hydroxyphenyl)prop-2-en-1-one→3-(3,4-dimethoxyphenyl)-1-(3-hydroxyphenyl)propan-1-one→tert-butyl 2-(3-(3-(3,4-dimethoxyphenyl)propanoyl)phenoxy)acetate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.